Please login to the form below

Not currently logged in
Email:
Password:

Sanofi to make generic Lipitor

Sanofi is to launch a generic version of Pfizer's blockbuster anticholesterol Lipitor, which is due to lose patent protection in 2012

Sanofi is to launch a generic version of Pfizer's blockbuster anticholesterol Lipitor (atorvastatin calcium) according to a report by French newspaper Les Echos that cites two sources involved in the matter.

The sources suggest that Sanofi may even be allowed to manufacture commercial lots of atorvastatin before full European patent protection is lost on May 7, 2012.

The agreement would be part of France's Strategic Council of Health Industries (CSIS) programme.

The programme offers tax rebates to the company who holds the rights to the original drug, in this case Pfizer, if production of its generic alternative is based in France.

Lipitor's patent was extended from November 2011 by six months in Europe due to the launch of a new version of the drug for children.

Generic versions of the drug are already available in certain countries including Spain, Brazil and Mexico, with Lipitors second quarter sales down from $2.81bn in 2010 to $2.59bn in 2011.

The Sanofi story comes the day after Dr Reddy's Laboratories announced it had settled a lawsuit with Pfizer regarding its plan to launch its own generic version of the drug.

Dr. Reddy's filed for approval of a generic version of Lipitor in 2009, with Pfizer claiming this infringed on the patents supporting Lipitor.

Other companies with generic versions of Lipitor lined up include Mylan, Ranbaxy Laboratories, Teva Pharmaceutical and Watson Pharmaceuticals.

1st September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics